Innovative Industrial Properties, Inc.
How Did Cannabis Stocks Perform Last Week?
Tilray (TLRY) stock fell as much as 5.5% last week, while Supreme Cannabis (SPRWF) fell ~4.4% in the week ending May 3.
How Valuation Multiples Stack Up for HEXO, CTST, IIPR, and Peers
As of March 22, the median forward EV-to-sales multiple of cannabis players was 7.0x.
Innovative Industrial Properties Declared Q1 Dividend
On March 12, Innovative Industrial Properties’ board declared its first-quarter dividend. The company declared a dividend of $0.45 per share.
March Valuation Update for CTST, HEXO, KSHB, and Others
In this article, we’ll discuss valuation multiple updates for other cannabis stocks that have gained investors’ attention lately.
Will IIPR Still Be an Investor Favorite Post Q3 Earnings?
Innovative Industrial Properties (IIPR) is set to report its third-quarter results tomorrow. IIPR stock, up 67.2% year-to-date, has been investor favorite.
Biggest Gainers in the Cannabis Sector Last Week
In the week ending April 5, the overall cannabis sector ended in the positive territory. HMMJ rose ~0.93% last week.
SLNG, IIPR, and CTST Gain amid Sector Weakness
The broader cannabis sector has traded largely in the negative so far on April 8 as investors have continued to be bearish.
Comparing the Valuation Multiples of Cannabis Stocks
In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.
Cannabis Roundup: ACB, HEXO, and CTST Lead the Pack
On March 13, during the first half of the day, the overall cannabis sector traded higher.
Cannabis Stocks Continue to Struggle on the Last Day of April
The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.
Cannabis Sector 2019 Review and 2020 Outlook
Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.
These Cannabis Stocks Rose amid Sector Weakness
While the overall cannabis sector experienced weakness on April 23, some stocks managed to gain some positive momentum in the first half of the day.
What to Expect from IIPR’s Earnings for Q3
Innovative Industrial Properties (IIPR) is scheduled to release its Q3 earnings results on November 6. Find out what cannabis investors can expect.
Cannabis Sector: A Week in Review for Sept 20
Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.
Which Cannabis Stocks Have Lost More than 40% in 2019?
The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.
IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.
Tilray’s Q2 Earnings Are Out: Did It Impress?
In its Q2 earnings report today, Tilray reported a 371% YoY revenue increase to $45.9 million. Tilray beat analysts’ estimate of $41.1 million in revenue.
Canopy Growth and Cronos Group’s Earnings Next Week
Canopy Growth (CGC) (WEED) and Cronos Group (CRON) are set to release their earnings next week. The cannabis sector has been on a roller coaster this year.
New Year Will Bring Legal Marijuana to Illinois Residents
Marijuana products are top-rated among Americans. Illinois will see recreational marijuana products for sale on January 1.
New Gallup Poll on Marijuana Legalization Support
A recent Gallup poll data found that nearly 66% of Americans support making cannabis legal. However, this figure was the same as in 2018. This suggests a standstill in the rise in support of cannabis legalization. Moreover, nine states will be voting in 2020 on measures to allow cannabis for recreational or medical use. The […]
IIPR Stock Moves Higher after New Debt Is Raised
Last week, Innovative Industrial Properties (IIPR) offered $125 million in senior notes, giving initial investors the option to exercise $18.75 million in additional principal amount notes.
Why Marijuana Is Thriving in Colombia
Colombia legalized medical marijuana in 2015. Now, it’s working on its booming medical cannabis industry. Let’s take a look at how.
Tilray Gets US Government’s Approval to Import CBD
On August 8, Tilray announced that it had received approval to import cannabis into the US to conduct two clinical trials related to cannabidiol.
Cannabis Stocks Roundup: Today’s Gains and Losses
In the previous part of this series, we saw that most cannabis stocks (MJ) were trending lower today, but there were some gains as well.
Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.
APHA, CRON, and Other Cannabis Stocks Resume Their Falls
On May 2, the overall sentiment surrounding the cannabis sector appeared to be negative.
What to Expect from KushCo Holdings’ Q3 Earnings
KushCo Holdings will likely report its third-quarter results on Wednesday. The company will have an earnings call before the market opens.
Innovative Industrial Properties Raises More Cash amid Crisis
On June 30, Innovative Industrial Properties announced its decision to raise additional capital of $225 million through a public offering of its common stock.
IIPR Acquires Another Property in Pennsylvania
Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.
Marijuana Legalization: New Zealand Has a Final Proposal
In New Zealand, marijuana legalization’s fate depends on the September general elections. The country has a final bill to put on the ballot.
IIPR Stock Falls after Reporting Weak Q1 Performance
On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.
Should You Buy IIPR before Its Q1 Earnings?
IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?
Marijuana Investors: Forecast in May amid COVID-19
We still don’t know how COVID-19 will impact marijuana companies. Their sales will likely keep rising in May if lockdowns and stay-at-home orders continue.
Analysts Cut Target Prices after HEXO’s Q2 Earnings
Hexo (TSE:HEXO) reported its second-quarter earnings on March 30. For the quarter, the company missed analysts’ revenue expectations marginally.
Should You Consider Buying Aurora Cannabis?
Aurora Cannabis (NYSE:ACB) is one of the few cannabis companies that has lost more than half of its market capitalization this year.
3 Cannabis Stocks Investors Should Watch as Markets Rebound
As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.
What to Expect from Charlotte’s Web’s Q4 Earnings
Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.
Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating
On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.
IIPR Looks Promising amid Struggling Cannabis Sector
As of March 11, Innovative Industrial Properties (NYSE:IIPR) was trading at $76.96—a rise of 1.4% since the beginning of this year.
IIPR Posts Impressive Q4 Earnings, Looks Strong in 2020
On Wednesday, IIPR reported its fourth-quarter earnings. The company reported revenues of $17.7 million, which beat analysts’ expectations of $14.4 million.
What Can You Expect from IIPR’s Q4 Earnings?
IIPR will report its results for the fourth quarter of 2019 today after the market closes. Analysts expect the company to post revenue and EPS growth.
IIPR Enters a Long-Term Agreement with GTI
Yesterday, IIPR announced that it bought a licensed cannabis processing facility in Toledo, Ohio, from Green Thumb Industries for $2.9 million.
Innovative Industrial Properties Company Overview
Innovative Industrial Properties, Inc. (IIPR) is the first company to focus on investing in real estate for medical marijuana companies. The company combines investments from investors and purchase real estate. Then, it leases it to companies that produce and sell medical marijuana. The portfolio of the company specializes in cannabis industry sites and greenhouse facilities. […]
IIPR: How to Invest in Cannabis and Still Make Money
While cannabis investors lost a lot of wealth last year, one stock continued to deliver staggering returns—Innovative Industrial Properties (IIPR).
Illinois Wakes Up to Legalized Recreational Cannabis
On June 25, Illinois governor J.B. Pritzker signed a bill approving marijuana use for everyone over 21 years old. The law became effective on January 1.
Is Green Thumb a Good Buy in December 2019?
Green Thumb Industries (GTII) (GTBIF) is a cannabis CPG (consumer packaged goods) company and retailer with headquarters in Chicago, Illinois.
Cannabis Update: GTII, KSHB, IIPR, and CTST
Today, the cannabis sector was trading in the red, with multiple ETFs losing ground. Here, we’ll have a look at cannabis stocks that are in the news today.
A Deep Dive into the Top Cannabis Retailers in Florida
Since Florida legalized medical marijuana, business is booming. In September, the state had 22 licensed vertically integrated medical cannabis operators.
CannTrust Stock Fell 22% Due to New Information
On Wednesday, CannTrust (CTST) stock fell almost 22.5% after new information came to light. The information came from a report by The Globe and Mail.
Why Cannabis Stocks Are Trending Down Today
Today, the cannabis sector was trading in the red despite the broader US equity market trading in the green. Here’s what’s going on.
Cannabis Stocks: Revisiting Their Valuations in November
Although near-term weakness exists in the cannabis stocks, we expect Cannabis 2.0 products or cannabis-derived products could act as a catalyst.
Cresco Labs’ Q3 Results Are Coming Up: What to Know
US-based vertically-integrated cannabis player Cresco Labs is set to report its fiscal 2019 third-quarter results on November 26.
Bank of America Upgrades Canopy Growth to ‘Buy’
Canopy Growth (WEED)(CGC) got a rare upgrade to “buy” from Bank of America today. Find out what drove the change—and what’s next.
The Cannabis Sector Continues Its Disappointing Week
After falling for the first two days this week, the cannabis sector maintained that weakness today. Let’s look at some cannabis stocks that are in the news.
IIPR’s Valuation Multiples Rise after Q3 Earnings Release
As of November 8, IIPR was trading at $85.22, which represents an increase of 17.4% since its third-quarter earnings release on November 6.
Charlotte’s Web: What to Expect from Q3 Earnings
Charlotte’s Web Holdings (CWEB) (CWBHF) will report third-quarter earnings before the market opens on November 13. Let’s look at analysts’ expectations.
IIPR, ACB, WEED, KSHB: Which Cannabis Stock Is Up?
The cannabis sector’s down despite strong broader-market performance. Between IIPR, Aurora, Canopy Growth, and KushCo, only this one stock is up today.
IIPR Stock Rises after Revenue and EPS Beat
Yesterday, Innovative Industrial Properties (IIPR) reported its Q3 earnings results. The company beat analysts’ revenue and EPS estimates.
Marijuana in Wisconsin: Five Things You Need to Know
On October 30, Wisconsin lawmakers introduced a bill to decriminalize marijuana possession. Here are five things to know about Wisconsin and legalization.
Cannabis News Driving CURLF, IIPR, GTII, HEXO Today
CNBC reports that Chinese officials aren’t confident of sealing a long-term US trade agreement. The cannabis sector was trading in the red today.
IIPR-Trulieve Real Estate Deal in Florida
Innovative Industrial Properties (IIPR), the first real estate investment trust in the medical marijuana segment, used $17 million to buy a cannabis cultivation facility in Florida. IIPR buys and rents industrial warehouses in the cannabis sector. More about the deal On October 23, 2019, IIPR bought a 120,000-square-foot property with five-building cultivation establishment for $17 […]
Cannabis Stocks Rise: CURLF, IIPR, ACB, WEED
After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.
Smokable Hemp: Banned in North Carolina in May 2020
When May 1, 2020, rolls around, you’ll won’t be able to smoke hemp in North Carolina legally. Just yesterday, the North Carolina House passed the North Carolina Farm Act with revisions to restrict smokable hemp. Why was it banned? The smokable hemp ban was widely supported by law enforcement agencies. Law enforcement officers might find […]
Cannabis Roundup: IIPR, ACB, and WEED
Cannabis ETFs, which fell yesterday, showed some recovery today. Also, the majority of the cannabis stocks were trading in the green.
Cannabis Roundup on TLRY, IIPR, ACB, and WEED
Although the broader equity market was flat, most of the cannabis stocks were trading in the red, as Aurora Cannabis fell 1.2% and Canopy Growth slid 2.2%.
Cannabis Roundup: CL, IIPR, CRON, and HEXO
At 12:50 PM ET, the S&P 500 Index and the Dow Jones Industrial Average were down 0.6% and 0.3%. Cannabis stocks showed mixed performances.
How Aleafia Health Expects to Become Profitable in Q3
On September 24, Aleafia Health (ALEF) (ALEAF) announced that it expects to report positive net profits in the third quarter.
Cannabis Roundup: IIPR, WEED, ACB, and APHA
The markets were flat today as the Fed started its two-day meeting. Cannabis ETFs reported mixed performance, and cannabis stocks traded mostly in the red.
Medical Cannabis: New State Law in Oklahoma
There’s a new law for medical cannabis in Oklahoma. The new law aims to regulate product labeling and drug testing policies.
Cannabis Roundup: IIPR, CRON, and CURA
The new tariffs saw the broader equity market trading in the red today. However, the cannabis sector was trading in the green.
Cannabis Legalization: Did President Trump Drop a Hint?
Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.
Aphria Has Analysts Feeling Optimistic—Here’s Why
Aphria (APHA) reported excellent fiscal 2019 fourth-quarter earnings results this month, after which its stock saw a huge boost.
Canopy Growth: What to Expect from Its Earnings Today
Canopy Growth (CGC) (WEED) is scheduled to announce its results for the first quarter of fiscal 2020 after the market closes on Wednesday.
Marijuana and Trade War: Will Democrats’ Agenda Intensify?
The trade war might impact the marijuana industry. The US-China trade war has been an ongoing issue. President Trump imposed tariffs on China in May.
Bernie versus Joe: Who Has a Better Marijuana Campaign?
Bernie Sanders versus Joe Biden! Who do you think has a better marijuana campaign? The 2020 presidential election is heating up.
Could President Trump Boost the Cannabis Industry?
President Trump might be waiting to use cannabis as a key platform during the upcoming election. Cannabis is a hot sector right now!
Cannabis Industry: FBI Investigation Poses Challenges
The cannabis industry has been in the spotlight this year, and now the FBI is investigating allegations of corruption in this nascent industry.
Canopy Growth Earnings Impacted the Cannabis Sector
Canopy Growth’s weak results weighed on the entire cannabis sector. Most of the cannabis stocks were in the red on Thursday.
Is the Cannabis Industry Recession-Proof?
The cannabis industry has become a favorite among investors. The industry saw a boom due to easing regulations. Major players have shown growth potential.
President Trump: Is Marijuana Legalization a Key Weapon?
President Trump hasn’t shared his views on marijuana yet. However, the US 2020 election is heating up. Many Democratic candidates have chosen marijuana legalization as a political platform. President Trump and the 2020 presidential election Some of the candidates have shared their views on marijuana legalization. Recently, we discussed what Bernie Sanders said about marijuana. […]
Why IIPR’s Q2 Earnings Came in Strong
Innovative Industrial Properties (IIPR) reported strong earnings results yesterday for the second quarter of 2019. Here’s what drove the results.
IIPR’s Q2 Earnings Call: Key Takeaways for Investors
So far, Innovative Industrial Properties (IIPR) stock has been impressive in 2019. The stock has gained almost 126% year-to-date.
Aurora Cannabis Is Upsizing Its Secured Credit Facility
Aurora Cannabis (ACB) announced that it’s increasing its secured credit facility to 360 million Canadian dollars from $200 million Canadian dollars.
Jim Cramer Thinks Cannabis Is Back in Action
Jim Cramer, the widely followed host of CNBC’s Mad Money, shared his views on the cannabis sector. He thinks that cannabis is hot right now.
MedMen Reports Its Preliminary Revenue for Q4
Today, MedMen Enterprises (MMEN) (MMNFF) reported its unaudited revenue for the fourth quarter of fiscal 2019.
Which Are the Best Cannabis Stocks in August?
Generally speaking, the cannabis sector’s valuations have taken a hit due to weak earnings. Recently, Aphria (APHA) posted better-than-expected earnings.
Tilray: What to Expect from Its Q2 Earnings Today
Tilray (TLRY) is scheduled to release its second-quarter results today after the market closes. Lately, Tilray stock has been off the radar.
Cresco Labs Lands New York Deal before Earnings
Cresco Labs is due to report its Q2 earnings on August 21 after the market closes. A week ahead, it received regulatory approval for a New York deal.
Why Cronos Group’s Q2 Earnings Failed to Impress
Yesterday, Cronos Group (CRON) reported better-than-expected second-quarter sales, but its operating loss widened.
Here’s How Aphria Plans to Drive Sales
When it reported its fiscal 2019 fourth-quarter results last week, Aphria (APHA) shared updates on its LATAM acquisition and its sales strategy.
Arizona Beverages to Introduce Cannabis Vape and Gummies
Arizona Beverages announced that it entered the cannabis market. The company signed a three-year licensing agreement with Dixie Brands.
APHA, IIPR, and CRON Earnings Move Cannabis Stocks
Cronos Group (CRON), Innovative Industrial Properties (IIPR), and Aphria’s (APHA) recent earnings are moving cannabis stocks.
IIPR: Will Its Q2 Earnings Impress Investors?
Innovative Industrial Properties (IIPR) is scheduled to announce its second-quarter results after the market closes on Wednesday.
IIPR Continues to Slump Ahead of Its Earnings
Innovative Industrial Properties (IIPR) continued to slump on July 22. The stock lost almost 6.8% of its value on the day.
Innovative Industrial Properties Signals That It’s Overpriced
On Thursday, Innovative Industrial Properties (IIPR) announced that it will issue approximately 1.3 million common shares to the public.
Innovative Industrial Properties Continues Its Stellar Run
On Tuesday, Innovative Industrial Properties (IIPR) gained nearly 6.2% and closed at $132.3. The stock has risen since the beginning of June.
Why Oppenheimer Cut HEXO’s Rating
Yesterday, HEXO (HEXO) ended the day about 4.5% lower after Oppenheimer cut the company’s ratings to “perform” from its previous “outperform” rating. HEXO was one of the best performers among the Canadian cannabis companies with a YTD return of 53%, which is still impressive when compared with Tilray (TLRY), which is in the negative territory YTD.
Innovative Industrial Properties’ Consensus Target Price Rose
Innovative Industrial Properties (IIPR) has seen some of the strongest momentum in June. The stock has gained almost 54%. On June 25, the stock rose 5.9%.
Innovative Industrial Properties’ Valuation: Stock Looks Risky
Innovative Industrial Properties has consistently traded at a premium to the peer median since August 2018. Currently, the company’s forward EV-to-sales multiple is trading at 20x.
Revisiting Aurora Cannabis’s Valuations at End of June
As of June 21, Aurora Cannabis was trading at 13.9x. Over this period, the peer median was also trading lower at 5.8x, which was almost 9.5% lower than our previous update. Thus, Aurora Cannabis has been pretty resilient compared to its peers.